GLP-1 agonist drugs have forever changed the weight-loss landscape. Ordinary people and celebrities alike have undergone dramatic and rapid transformations while taking them. While GLP-1 users often see remarkable fat loss, many also lose significant quantities of lean mass. BioLongevity Labs is hoping to change that. Studies have indicated muscle loss accounts for 25%–39% of […] The post BioLongevity Labs Founder on the New Generation of “Muscle-Sparing” Peptides Helping GLP-1 Users Prevent Muscle Loss appeared first on LA Weekly .